MoneyWorks4Me

The revenue for the March 2022 quarter is pegged at Rs. 12550.20 millions, about 14.56% up against Rs. 10955.40 millions recorded during the year-ago period.Good  Net Profit growth of 38.66% reported above the corresponding previous quarter figure of Rs. 1524.70 millions to Rs. 2114.10 millioins.OP of the company witnessed a marginal growth to 3148.70 millions from 2217.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 12550.20 10955.40 14.56 49192.70 43100.20 14.14 49192.70 43100.20 14.14
Other Income 210.50 162.00 29.94 772.10 809.00 -4.56 772.10 809.00 -4.56
PBIDT 3148.70 2217.30 42.01 11649.30 10023.60 16.22 11649.30 10023.60 16.22
Interest 51.40 47.40 8.44 191.00 182.80 4.49 191.00 182.80 4.49
PBDT 3097.30 2169.90 42.74 11458.30 9840.80 16.44 11458.30 9840.80 16.44
Depreciation 174.30 151.10 15.35 661.00 581.30 13.71 661.00 581.30 13.71
PBT 2923.00 2018.80 44.79 10797.30 9259.50 16.61 10797.30 9259.50 16.61
TAX 808.90 494.10 63.71 2810.30 2352.60 19.46 2810.30 2352.60 19.46
Deferred Tax 74.20 10.70 593.46 41.80 -37.90 -210.29 41.80 -37.90 -210.29
PAT 2114.10 1524.70 38.66 7987.00 6906.90 15.64 7987.00 6906.90 15.64
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 25.09 20.24 23.96 23.68 23.26 1.82 23.68 23.26 1.82
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..